Synthetic Biology Category Wins the 350th Anniversary Merck Innovation Cup.

biotechnological projects brainstorm business plan early career scientists professional network scientific event

Journal

Trends in biotechnology
ISSN: 1879-3096
Titre abrégé: Trends Biotechnol
Pays: England
ID NLM: 8310903

Informations de publication

Date de publication:
01 2020
Historique:
received: 28 08 2019
revised: 16 10 2019
accepted: 17 10 2019
pubmed: 14 11 2019
medline: 22 6 2021
entrez: 14 11 2019
Statut: ppublish

Résumé

Over the past 350 years, Merck has developed science and technology especially in health care, life sciences, and performance materials. To celebrate so many productive years, Merck conducted a special expanded anniversary edition of the Innovation Cup in combination with the scientific conference Curious2018 - Future Insight in Darmstadt, Germany.

Identifiants

pubmed: 31718803
pii: S0167-7799(19)30248-3
doi: 10.1016/j.tibtech.2019.10.007
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-4

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Ângelo P Matos (ÂP)

Federal University of Santa Catarina, Florianopolis, Brazil; Murdoch University, Murdoch, Australia. Electronic address: angelosotam@gmail.com.

Amy Kauffman (A)

Yale University, New Haven, CT, USA.

Christopher Vickery (C)

Harvard University, Boston, MA, USA.

Kaleb Naegeli (K)

University of North Carolina, Chapel Hill, NC, USA.

Lisa Strittmatter (L)

University of Cambridge, Cambridge, UK.

Anastasiya Sybirna (A)

University of Cambridge, Cambridge, UK.

Janneke van Blijswijk (J)

London Research Institute, London, UK.

Lorenz Adlung (L)

Weizmann Institute of Science, Rehovot, Israel.

Tetyana Berbasova (T)

Yale University, New Haven, CT, USA.

Jhon Enterina (J)

University of British Columbia, Vancouver, Canada.

Lena Eismann (L)

Heidelberg University, Heidelberg, Germany.

Braden Tierney (B)

Harvard University, Boston, MA, USA.

Josua Jordi (J)

Harvard University, Cambridge, MA, USA.

Lian Zhu (L)

Princeton University, Princeton, NJ, USA.

Sebald Verkuijl (S)

University of Oxford, Oxford, UK.

Lorillee Tallorin (L)

Harvard University, Boston, MA, USA.

Arne Wehling (A)

ETH Zurich, Basel, Switzerland.

Michael Ogden (M)

University of Melbourne, Melbourne, Australia; Max Planck Institute of Molecular Plant Physiology, Potsdam-Golm, Germany.

Stephan Lammel (S)

University of California, Berkeley, Berkeley, CA, USA.

Maike K Hasslacher (MK)

Merck KGaA, Innovation and Entrepreneurship Incubator/Future Insight, Darmstadt, Germany.

Petra Wuelfroth (P)

Acella Advisors, Zurich, Switzerland.

Siegfried Neumann (S)

Technical University of Darmstadt, Darmstadt, Germany.

Christian Tidona (C)

BioMed X Innovation Center, Heidelberg, Germany.

Ulrich A K Betz (UAK)

Merck KGaA, Innovation and Entrepreneurship Incubator/Future Insight, Darmstadt, Germany. Electronic address: ulrich.betz@merckgroup.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH